Researchers discover possible new biomarker of MS-like autoimmune disease

It has been known for several years that the diagnosis “multiple sclerosis” conceals a whole range of different illnesses, each requiring customized treatment. Researchers at the University of Basel and the University Hospital of Basel have now described a possible new MS-like disease and explained how to diagnose it.

Opinion | No Laughing Matter: Women’s Health Is Not a ‘Women’s Issue’

Rosen is a professor of cardiology. Stand-up comics aren’t usually my go-to source for making a professional point. But a searing insight from Amy Schumer

November 27, 2023

Novartis’ Scemblix gains FDA approval for leukaemia treatment

In the ASC4FIRST trial, Scemblix showed superior MMR rates at week 48 compared to standard-of-care TKIs and imatinib alone. Credit: Elle Aon/Shutterstock. Novartis has received

October 30, 2024

Tattoo-less radiation treatment is the future of cancer care

Tattoos are often seen as powerful expressions of individuality. In the medical world, however, they can serve as unwanted reminders of a difficult past. For

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.